By vgreene, 20 December, 2019 Flex sig guidance differs. Options: q5y per ACS,S or flex sig q10y + FIT q2y per ACPP (ACG/AGA/AGSE1 considers it 2nd-tier)
By vgreene, 20 December, 2019 Screen pts w a single affected1 relative w standard options start earlier per ACG 1 then resume average risk recommendations
By vgreene, 20 December, 2019 CT colonography q5y, FIT-sDNA q3y, or flex sig q5-10y; if all of these are declined, then capsule colonoscopy q5y (3rd-tier)
By vgreene, 20 December, 2019 If continued screening factor pt preference set frequency based on screen type Empirical data aren t available to demonstrate greater net benefit of one screening strategy over another 4
By vgreene, 20 December, 2019 Not recommended Per ACG Septin 9 testing1 Per ACP Stool DNA CT colonography capsule endoscopy urine or serum tests3
By vgreene, 20 December, 2019 2nd line screens 4 Stool DNA mt sDNA q3y per ACG 1 ACS2 CT colonography q5y per ACG 1 ACS 2 USPSTF4 Colon capsule also 2nd tier per ACG 1 w q5y interval